España
India
Italia
대한민êµ
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Penumbra
PEN
NYSE
Watchlist
Get Report
Perks
Buy
Compare Brokers
$175.66
-3.61
-2.01%
Last update: 11:04 AM
15 minutes delayed
Get Report
Watch
Penumbra (PEN) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Penumbra (NYSE:PEN) Stock
Penumbra Stock (NYSE: PEN)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, June 21, 2024
Top 3 Health Care Stocks That Could Blast Off In June
Avi Kapoor
Monday, June 10, 2024
Peering Into Penumbra's Recent Short Interest
Benzinga Insights
Thursday, May 23, 2024
Looking Into Penumbra's Recent Short Interest
Benzinga Insights
Wednesday, May 08, 2024
Canaccord Genuity Maintains Buy on Penumbra, ...
Benzinga Newsdesk
Piper Sandler Maintains Overweight on Penumbr...
Benzinga Newsdesk
The Latest Analyst Ratings For Penumbra
Benzinga Insights
Needham Reiterates Hold on Penumbra
Benzinga Newsdesk
Tuesday, May 07, 2024
Penumbra Reiterates FY24 Revenue $1.230B-$1.2...
Benzinga Newsdesk
Penumbra Q1 Adj $0.41 Beats $0.38 Estimate, S...
Benzinga Newsdesk
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
Tuesday, April 23, 2024
Penumbra Announced The US Food And Drug Admin...
Benzinga Newsdesk
Tuesday, April 09, 2024
Jim Cramer Was Upset At This Hostile Takeover, But 'They Fixed The Situation. Stock's Been A Horse'
Avi Kapoor
Wednesday, April 03, 2024
Piper Sandler Reiterates Overweight on Penumb...
Benzinga Newsdesk
Friday, March 22, 2024
Penumbra Stock: A Deep Dive Into Analyst Perspectives (8 Ratings)
Benzinga Insights
Truist Securities Maintains Buy on Penumbra, ...
Benzinga Newsdesk
Friday, February 23, 2024
Why MercadoLibre Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
RBC Capital Reiterates Outperform on Penumbra...
Benzinga Newsdesk
Canaccord Genuity Reiterates Buy on Penumbra,...
Benzinga Newsdesk
Penumbra shares are trading lower after the c...
Benzinga Newsdesk
Intuit To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Friday
Avi Kapoor
Where Penumbra Stands With Analysts
Benzinga Insights
JP Morgan Downgrades Penumbra to Neutral, Low...
Benzinga Newsdesk
Thursday, February 22, 2024
Penumbra Sees FY24 Revenue $1.23B-$1.27B Vs $...
Benzinga Newsdesk
Penumbra shares are trading lower after the c...
Benzinga Newsdesk
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
Penumbra: Q4 Earnings Insights
Benzinga Insights
Penumbra Q4 2023 Adj EPS $0.76 Beats $0.70 Es...
Benzinga Newsdesk
Earnings Scheduled For February 22, 2024
Benzinga Insights
Wednesday, February 21, 2024
Earnings Preview For Penumbra
Benzinga Insights
Tuesday, February 13, 2024
How Is The Market Feeling About Penumbra?
Benzinga Insights
Friday, January 12, 2024
RBC Capital Maintains Outperform on Penumbra,...
Benzinga Newsdesk
Thursday, January 11, 2024
Deep Dive Into Penumbra Stock: Analyst Perspectives (6 Ratings)
Benzinga Insights
RBC Capital Maintains Outperform on Penumbra,...
Benzinga Newsdesk
Friday, December 22, 2023
Truist Securities Maintains Buy on Penumbra, ...
Benzinga Newsdesk
Wednesday, December 20, 2023
JP Morgan Maintains Overweight on Penumbra, R...
Benzinga Newsdesk
Tuesday, December 12, 2023
Expert Ratings for Penumbra
Benzinga Insights
Truist Securities Maintains Buy on Penumbra, ...
Benzinga Newsdesk
Wednesday, December 06, 2023
Penumbra EVP Sold $135K In Company Stock
Benzinga Insights
Tuesday, November 28, 2023
First Patient In STORM-PE RCT Enrolled Evalua...
Benzinga Newsdesk
Monday, November 13, 2023
Why Edible Garden Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin
Shares of medical device and diabetes care st...
Benzinga Newsdesk
Monday.Com Reports Q3 Beat, Joins Fortrea Holdings, Henry Schein And Other Big Stocks Moving Higher On Monday
Lisa Levin
Friday, November 03, 2023
Piper Sandler Maintains Overweight on Penumbr...
Benzinga Newsdesk
What 5 Analyst Ratings Have To Say About Penumbra
Benzinga Insights
Morgan Stanley Maintains Equal-Weight on Penu...
Benzinga Newsdesk
Thursday, November 02, 2023
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
Penumbra Sees Q4 2023 Revenue Growth To Accel...
Benzinga Newsdesk
Penumbra Q3 Adj $0.67 Beats $0.45 Estimate, S...
Benzinga Newsdesk
Earnings Scheduled For November 2, 2023
Benzinga Insights
Thursday, October 12, 2023
Penumbra Chief Accounting Officer Acquires 2,750 Shares After Exercising Company Stock Options
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch